PHARMACEUTICAL MARKET ANALYSIS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN UKRAINE
The Ukrainian pharmaceutical market of non-steroidal anti-inflammatory drugs (NSAIDs) has been investigated with the purpose of providing the population with effective, safe and qualitative medicines. NSAIDs occupy an important segment at the pharmaceutical market and belong to the most spread medicines. Due to their unique pharmacological properties (anti-inflammatory, analgesic, antipyretic and antithrombotic) these medicines are used not only in rheumatology, but almost in all branches of medicine. The review of the pharmaceutical market has demonstrated that a great part of the NSAIDs range is medicines of foreign companies that manufacture 168 medicines, among them 37 medicines are combined. Domestic medicines consist of 46 medicines and 8 combined ones. The Ukrainian market is formed by the foreign manufacturers and it is three times higher than domestic companies offer. The most relevant positive trends of development of this market segment are expansion of the assortment and variety of trade names and drug dosage forms presented by medicines.